Gothenburg MCI study
The Gothenburg mild cognitive impairment (MCI) study, launched in 1999, is a single-center clinical-pathophysiologic study investigating early and manifest phases of Alzheimer’s disease (AD) and vascular dementia (VaD). Patients are referred to the memory clinic at the Sahlgrenska University Hospital in Mölndal, Sweden. Patients are aged between 50 and 79 years, have a mini mental state examination (MMSE) result above 18, present with self- or informant-reported cognitive decline, and have a duration of cognitive decline of 6 months or more. All participants are examined at baseline and after 2, 4, 6, and 10 years.
Study design
Cohort - clinical
Number of participants at first data collection
664 (participants)
115 (controls)
Age at first data collection
50 - 79 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
A population of memory clinic patients between 1999 and 2013.
Sample features
Country
Year of first data collection
1999
Primary Institutions
University of Gothenburg (Göteborgs universitet)
Profile paper DOI
Funders
Adlerbert Research Foundation
Alzheimer’s Association
Gothenburg Medical Society (Göteborgs Läkaresällskap)
Gun and Bertil Stohne's Foundation (Gun och Bertil Stohnes stiftelse)
Inga Britt & Arne Lundberg Research Foundation
Ongoing?
Yes
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- None
- Electroencephalography (EEG)
- Magnetic Resonance Imaging (MRI)
- Single-photon emission computed tomography (SPECT)
- None
Engagement
Keywords
